Healthcare provider profile · identity verified

Selim Uddin Sheikh, MD

Internal Medicine · HAMILTON, NJ · NPI 1992921811

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	550	132
Levothyroxine Sodium	Levothyroxine Sodium	401	63
Amlodipine Besylate	Amlodipine Besylate	304	74
Eliquis	Apixaban	247	34
Pantoprazole Sodium	Pantoprazole Sodium	236	60
Metoprolol Succinate	Metoprolol Succinate	210	53
Metformin Hcl	Metformin Hcl	194	56
Losartan Potassium	Losartan Potassium	174	46
Lisinopril	Lisinopril	172	44
Furosemide	Furosemide	152	31
Rosuvastatin Calcium	Rosuvastatin Calcium	143	29
Tamsulosin Hcl	Tamsulosin Hcl	137	32
Metoprolol Tartrate	Metoprolol Tartrate	132	30
Escitalopram Oxalate	Escitalopram Oxalate	115	21
Potassium Chloride	Potassium Chloride	105	20
Carvedilol	Carvedilol	87	27
Gabapentin	Gabapentin	81	23
Clopidogrel	Clopidogrel Bisulfate	79	19
Simvastatin	Simvastatin	74	16
Omeprazole	Omeprazole	65	18
Alendronate Sodium	Alendronate Sodium	64	suppressed
Donepezil Hcl	Donepezil Hcl	64	11
Quetiapine Fumarate	Quetiapine Fumarate	60	suppressed
Mirtazapine	Mirtazapine	57	19
Latanoprost	Latanoprost	55	11
Januvia	Sitagliptin Phosphate	54	12
Chlorhexidine Gluconate	Chlorhexidine Gluconate	50	suppressed
Hydralazine Hcl	Hydralazine Hcl	50	12
Glimepiride	Glimepiride	48	15
Famotidine	Famotidine	46	suppressed
Xarelto	Rivaroxaban	46	13
Olanzapine	Olanzapine	45	suppressed
Risperidone	Risperidone	43	suppressed
Amiodarone Hcl	Amiodarone Hcl	41	suppressed
Levetiracetam	Levetiracetam	41	suppressed
Pravastatin Sodium	Pravastatin Sodium	41	suppressed
Sertraline Hcl	Sertraline Hcl	41	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	11
Metformin Hcl Er	Metformin Hcl	39	suppressed
Divalproex Sodium Er	Divalproex Sodium	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	38	15
Finasteride	Finasteride	37	suppressed
Divalproex Sodium	Divalproex Sodium	35	suppressed
Entresto	Sacubitril/Valsartan	35	suppressed
Ozempic	Semaglutide	35	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	34	16
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	32	suppressed
Valsartan	Valsartan	32	12
Carbidopa-Levodopa	Carbidopa/Levodopa	30	suppressed
Jardiance	Empagliflozin	30	suppressed
Trazodone Hcl	Trazodone Hcl	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Tradjenta	Linagliptin	29	suppressed
Brilinta	Ticagrelor	28	suppressed
Duloxetine Hcl	Duloxetine Hcl	28	suppressed
Irbesartan	Irbesartan	28	suppressed
Insulin Aspart Flexpen	Insulin Aspart	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	13
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Midodrine Hcl	Midodrine Hcl	24	suppressed
Nystatin	Nystatin	23	12
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Baclofen	Baclofen	21	suppressed
Timolol Maleate	Timolol Maleate	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	15
Advair Hfa	Fluticasone Propion/Salmeterol	19	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Prednisone	Prednisone	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	11
Allopurinol	Allopurinol	17	11
Carbamazepine	Carbamazepine	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Movantik	Naloxegol Oxalate	17	suppressed
Mupirocin	Mupirocin	17	12
Tramadol Hcl	Tramadol Hcl	17	suppressed
Azithromycin	Azithromycin	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Ammonium Lactate	Ammonium Lactate	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Linzess	Linaclotide	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	13	suppressed
Santyl	Collagenase Clostridium Hist.	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Alogliptin	Alogliptin Benzoate	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Bethanechol Chloride	Bethanechol Chloride	12	suppressed
Budesonide	Budesonide	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Donepezil Hcl Odt	Donepezil Hcl	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Mesalamine	Mesalamine	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Torsemide	Torsemide	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Letrozole	Letrozole	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error